34 results on '"Burks, A. Wesley"'
Search Results
2. State of the art on food allergen immunotherapy: Oral, sublingual, and epicutaneous
3. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy
4. National prevalence and risk factors for food allergy and relationship to asthma: Results from the National Health and Nutrition Examination Survey 2005-2006
5. Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy
6. Egg oral immunotherapy in nonanaphylactic children with egg allergy
7. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy
8. Long-Lasting Egg Consumption in Egg Allergic Children Treated with Oral Immunotherapy (OIT): Follow-up from the Consortium of Food Allergy Research (CoFAR) Study
9. Profile Of Food Allergen-Specific T Cells In Allergic and Clinically Tolerant Individuals
10. Length Of Avoidance Period Following Peanut Oral Immunotherapy Influences Effector Cell Suppression and Clinical Outcomes
11. Safety Of Pediatric Peanut Oral Immunotherapy Is Complicated By High Adverse Event Rates
12. Quality Of Life With Sublingual Immunotherapy For Peanut
13. Omalizumab Pretreatment Does Not Protect Against Peanut Oral Immunotherapy-Related Adverse Gastrointestinal Events
14. Increases In Peanut-Specific IgA1 and IgA2 During Peanut Immunotherapy Do Not Correlate With Clinical Tolerance
15. Peanut OIT-Induced IgG Suppresses Ex Vivo Activation Of Allergic Donor Basophils Via a Combination Of Antigen Interception and Receptor-Bound Inhibition
16. Induction Of Remission Of Frequent Idiopathic Anaphylaxis With Rituximab
17. Changes in IgE and IgG4 Indicative of Desensitization Are Associated with Ara h 1 and 2, but Not Ara h 3, 8, and 9, in Subjects On Sublingual Immunotherapy for Peanut Allergy
18. Clinical Factors and Laboratory Correlates of Egg Allergy Resolution in a Cohort of Infants with Egg Allergy (COFAR)
19. Low-Dose Oral Immunotherapy As an Early Intervention Strategy for Peanut Allergy
20. Tolerance Induction in an Interim Analysis of Peanut Sublingual Immunotherapy
21. Development of Tolerance Following Peanut Immunotherapy Is Associated with Basophil Hyporesponsiveness and Low Peanut-IgE:IgG4 Ratio
22. Impact of Food Allergy On Growth in the Pediatric Population
23. Predictors of Clinical Tolerance After Peanut Oral Immunotherapy
24. Negative Association of FoxP3 Regulatory T Cells with Anaphylaxis Upon Food Challenge in Murine Models of Peanut Allergy
25. Peanut Oral Immunotherapy Induces Desensitization At 2g Maintenance Dosing
26. Life with Peanut: Follow up of Tolerant Versus Desensitized Subjects After Peanut OIT
27. A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
28. Reply
29. Egg oral immunotherapy in nonanaphylactic children with egg allergy: Follow-up
30. Peanut oral immunotherapy is not ready for clinical use
31. Confirmation of autosomal dominant transmission of the DiGeorge malformation complex
32. Atopic dermatitis: Clinical relevance of food hypersensitivity reactions
33. Molecular analysis of X-linked agammaglobulinemia with growth hormone deficiency
34. Documentation of food hypersensitivity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.